Peptide record

TPDB06383

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06383
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 SATPdb dbACP iACP-DRLF Antifungipept CAFPdb AVPpred-BWR ToxinPred 3.0
standard
No
A 11-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
TESYFVFSVGM
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C59H83N11O18S1
ARNDCQHILKPW
FSV
1266.43
3.29
0
1
6
-1
-0.09
0.764
52.73
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
1490
1.18
4
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
1
G
0
H
0
I
0
L
0
K
1
M
2
F
0
P
2
S
1
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 0 L: 0 K: 0 M: 1 F: 2 P: 0 S: 2 T: 1 W: 0 Y: 1 V: 2
Chemical Descriptors
11 reviewed residue count
C59H83N11O18S1 sequence-only estimate (linear, free termini)
1266.43 sequence-only estimate (linear, free termini)
3.29 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-0.09 sequence-only estimate (linear, free termini)
0.764 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

MIC
Antibacterial
12.5-25 µM

Target

v. actinidiae

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against plant pathogens Gram- X. arboricola pv. pruni and P. syringae pv. actinidiae (MIC12.5-25 uM) ( Camó C et al. 2019 ). Cn-AMP2 has activity against human glioblastoma ( Prabhu S et al.
Evidence 2 Activity

Activity

MIC
Antifungal
12.5-25 µM

Target

v. actinidiae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against plant pathogens Gram- X. arboricola pv. pruni and P. syringae pv. actinidiae (MIC12.5-25 uM) ( Camó C et al. 2019 ). Cn-AMP2 has activity against human glioblastoma ( Prabhu S et al.
Evidence 3 Activity

Activity

MIC
Antiparasitic
12.5-25 µM

Target

v. actinidiae

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against plant pathogens Gram- X. arboricola pv. pruni and P. syringae pv. actinidiae (MIC12.5-25 uM) ( Camó C et al. 2019 ). Cn-AMP2 has activity against human glioblastoma ( Prabhu S et al.
Evidence 4 Activity

Activity

MIC
Antiviral
12.5-25 µM

Target

v. actinidiae

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against plant pathogens Gram- X. arboricola pv. pruni and P. syringae pv. actinidiae (MIC12.5-25 uM) ( Camó C et al. 2019 ). Cn-AMP2 has activity against human glioblastoma ( Prabhu S et al.
Evidence 5 Activity

Activity

8±2.7
Toxicity
375 µM
Hemolytic Cytotoxic
8±2.7 | 375 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptide KSL-W and analogues: Promising agents to control plant diseases. | Peptides | 2018